Viewing Study NCT00006903


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-01-03 @ 11:56 PM
Study NCT ID: NCT00006903
Status: UNKNOWN
Last Update Posted: 2019-03-20
First Post: 2000-12-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer
Sponsor: Gynecologic Oncology Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Uterine Corpus Carcinoma View
None Stage III Uterine Corpus Cancer AJCC v7 View
None Stage IV Uterine Corpus Cancer AJCC v7 View
Keywords: